DalsnaFinance › IPOs › Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. completed its initial public offering on NYSE on May 9, 2025, pricing at $4.00 a share.
| Ticker | APUS |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | May 9, 2025 |
| Offering price | $4.00 |
| Shares offered | 3,375,000 |
| Total raised | $14M |
IPO data is compiled from SEC filings. This page is general information, not investment advice.